Global GLP-1 for Diabetes Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301040003 | Category: Pharma & Healthcare | Pages: 96 | Format: PDF | Published Date: January 11,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global GLP-1 for Diabetes market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global GLP-1 for Diabetes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global GLP-1 for Diabetes market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 for Diabetes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 for Diabetes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 for Diabetes market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 for Diabetes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 for Diabetes market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Eli Lily, GSK and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
GLP-1 for Diabetes market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Injection
    Oral Agent
Market segment by Application
    Woman
    Man
Major players covered
    Novo Nordisk
    AstraZeneca
    Eli Lily
    GSK
    Sanofi
    Bristol-Myers Squibb
    Amylin
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GLP-1 for Diabetes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 for Diabetes, with price, sales, revenue and global market share of GLP-1 for Diabetes from 2018 to 2023.
Chapter 3, the GLP-1 for Diabetes competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 for Diabetes breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GLP-1 for Diabetes market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 for Diabetes.
Chapter 14 and 15, to describe GLP-1 for Diabetes sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of GLP-1 for Diabetes
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global GLP-1 for Diabetes Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Injection
        1.3.3 Oral Agent
    1.4 Market Analysis by Application
        1.4.1 Overview: Global GLP-1 for Diabetes Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Woman
        1.4.3 Man
    1.5 Global GLP-1 for Diabetes Market Size & Forecast
        1.5.1 Global GLP-1 for Diabetes Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global GLP-1 for Diabetes Sales Quantity (2018-2029)
        1.5.3 Global GLP-1 for Diabetes Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk GLP-1 for Diabetes Product and Services
        2.1.4 Novo Nordisk GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 AstraZeneca
        2.2.1 AstraZeneca Details
        2.2.2 AstraZeneca Major Business
        2.2.3 AstraZeneca GLP-1 for Diabetes Product and Services
        2.2.4 AstraZeneca GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 AstraZeneca Recent Developments/Updates
    2.3 Eli Lily
        2.3.1 Eli Lily Details
        2.3.2 Eli Lily Major Business
        2.3.3 Eli Lily GLP-1 for Diabetes Product and Services
        2.3.4 Eli Lily GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eli Lily Recent Developments/Updates
    2.4 GSK
        2.4.1 GSK Details
        2.4.2 GSK Major Business
        2.4.3 GSK GLP-1 for Diabetes Product and Services
        2.4.4 GSK GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 GSK Recent Developments/Updates
    2.5 Sanofi
        2.5.1 Sanofi Details
        2.5.2 Sanofi Major Business
        2.5.3 Sanofi GLP-1 for Diabetes Product and Services
        2.5.4 Sanofi GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Sanofi Recent Developments/Updates
    2.6 Bristol-Myers Squibb
        2.6.1 Bristol-Myers Squibb Details
        2.6.2 Bristol-Myers Squibb Major Business
        2.6.3 Bristol-Myers Squibb GLP-1 for Diabetes Product and Services
        2.6.4 Bristol-Myers Squibb GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bristol-Myers Squibb Recent Developments/Updates
    2.7 Amylin
        2.7.1 Amylin Details
        2.7.2 Amylin Major Business
        2.7.3 Amylin GLP-1 for Diabetes Product and Services
        2.7.4 Amylin GLP-1 for Diabetes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Amylin Recent Developments/Updates
3 Competitive Environment: GLP-1 for Diabetes by Manufacturer
    3.1 Global GLP-1 for Diabetes Sales Quantity by Manufacturer (2018-2023)
    3.2 Global GLP-1 for Diabetes Revenue by Manufacturer (2018-2023)
    3.3 Global GLP-1 for Diabetes Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of GLP-1 for Diabetes by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 GLP-1 for Diabetes Manufacturer Market Share in 2022
        3.4.2 Top 6 GLP-1 for Diabetes Manufacturer Market Share in 2022
    3.5 GLP-1 for Diabetes Market: Overall Company Footprint Analysis
        3.5.1 GLP-1 for Diabetes Market: Region Footprint
        3.5.2 GLP-1 for Diabetes Market: Company Product Type Footprint
        3.5.3 GLP-1 for Diabetes Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global GLP-1 for Diabetes Market Size by Region
        4.1.1 Global GLP-1 for Diabetes Sales Quantity by Region (2018-2029)
        4.1.2 Global GLP-1 for Diabetes Consumption Value by Region (2018-2029)
        4.1.3 Global GLP-1 for Diabetes Average Price by Region (2018-2029)
    4.2 North America GLP-1 for Diabetes Consumption Value (2018-2029)
    4.3 Europe GLP-1 for Diabetes Consumption Value (2018-2029)
    4.4 Asia-Pacific GLP-1 for Diabetes Consumption Value (2018-2029)
    4.5 South America GLP-1 for Diabetes Consumption Value (2018-2029)
    4.6 Middle East and Africa GLP-1 for Diabetes Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global GLP-1 for Diabetes Sales Quantity by Type (2018-2029)
    5.2 Global GLP-1 for Diabetes Consumption Value by Type (2018-2029)
    5.3 Global GLP-1 for Diabetes Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global GLP-1 for Diabetes Sales Quantity by Application (2018-2029)
    6.2 Global GLP-1 for Diabetes Consumption Value by Application (2018-2029)
    6.3 Global GLP-1 for Diabetes Average Price by Application (2018-2029)
7 North America
    7.1 North America GLP-1 for Diabetes Sales Quantity by Type (2018-2029)
    7.2 North America GLP-1 for Diabetes Sales Quantity by Application (2018-2029)
    7.3 North America GLP-1 for Diabetes Market Size by Country
        7.3.1 North America GLP-1 for Diabetes Sales Quantity by Country (2018-2029)
        7.3.2 North America GLP-1 for Diabetes Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe GLP-1 for Diabetes Sales Quantity by Type (2018-2029)
    8.2 Europe GLP-1 for Diabetes Sales Quantity by Application (2018-2029)
    8.3 Europe GLP-1 for Diabetes Market Size by Country
        8.3.1 Europe GLP-1 for Diabetes Sales Quantity by Country (2018-2029)
        8.3.2 Europe GLP-1 for Diabetes Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific GLP-1 for Diabetes Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific GLP-1 for Diabetes Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific GLP-1 for Diabetes Market Size by Region
        9.3.1 Asia-Pacific GLP-1 for Diabetes Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific GLP-1 for Diabetes Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America GLP-1 for Diabetes Sales Quantity by Type (2018-2029)
    10.2 South America GLP-1 for Diabetes Sales Quantity by Application (2018-2029)
    10.3 South America GLP-1 for Diabetes Market Size by Country
        10.3.1 South America GLP-1 for Diabetes Sales Quantity by Country (2018-2029)
        10.3.2 South America GLP-1 for Diabetes Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa GLP-1 for Diabetes Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa GLP-1 for Diabetes Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa GLP-1 for Diabetes Market Size by Country
        11.3.1 Middle East & Africa GLP-1 for Diabetes Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa GLP-1 for Diabetes Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 GLP-1 for Diabetes Market Drivers
    12.2 GLP-1 for Diabetes Market Restraints
    12.3 GLP-1 for Diabetes Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of GLP-1 for Diabetes and Key Manufacturers
    13.2 Manufacturing Costs Percentage of GLP-1 for Diabetes
    13.3 GLP-1 for Diabetes Production Process
    13.4 GLP-1 for Diabetes Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 GLP-1 for Diabetes Typical Distributors
    14.3 GLP-1 for Diabetes Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global GLP-1 for Diabetes Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?